The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 510.50
Bid: 512.00
Ask: 513.50
Change: -6.00 (-1.16%)
Spread: 1.50 (0.293%)
Open: 520.00
High: 520.00
Low: 510.50
Prev. Close: 516.50
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal programme successfully concluded

1 Mar 2023 07:00

RNS Number : 4744R
Babcock International Group PLC
01 March 2023
 

01 March 2023

 

Disposal programme successfully concluded

 

Babcock International Group PLC ("Babcock" or "the Group") is pleased to announce the conclusion of its portfolio alignment programme with the completion of the sale of certain of its aerial emergency businesses (AES) to Ancala Partners.

As announced on 19 July 2022, the AES businesses were sold for a cash consideration of €136.2 million (c. £120 million), before completion adjustments and transaction costs. The proceeds will be used to reduce debt.

This follows the sale of part of Babcock's civil training business to Inspirit Capital on 01 February 2023.

The completion of these two disposals concludes the Group's programme of portfolio alignment designed to reduce complexity, focus the Group on its chosen markets and strengthen the balance sheet.

The programme, initially announced on 13 April 2021, has generated gross proceeds of c. £570 million and transferred leases of c. £340 million. As a result, defence now accounts for around two-thirds of Group revenue.

Babcock CEO David Lockwood said:

"We've done what we said we'd do at the start of our turnaround: we've strengthened the balance sheet and reduced complexity. Around two-thirds of the Group is now focused on defence, and we are well positioned for future growth opportunities in our core markets.

"The AES and civil training businesses are both in good hands, and I wish their new owners every success in growing the businesses further."

 

ENDS

 

 

For further information:

 

Andrew Gollan, Director of Investor Relations

+44 (0)7936 039004

Kate Hill, Group Director of Communications

+44 (0)20 7355 5312

 

Tulchan Communications

 

Olivia Peters / Harry Cameron

+44 (0)20 7353 4200  

 

 

Note: The AES businesses sold provide aerial emergency medical services, firefighting and search & rescue to customers and communities in Italy, Spain, Portugal, Norway, Sweden and Finland and had revenue of £405 million in FY22 and a profit contribution of £13 million. Babcock retains its aerial emergency services businesses in its focus countries of the UK, France, Canada and Australia.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJBMFTMTBMMFJ
Date   Source Headline
26th Apr 20241:15 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSContract awarded to refit UK nuclear submarine
21st Feb 20245:58 pmRNSDirector/PDMR Shareholding
15th Feb 20247:05 amRNSDirector announcement
14th Feb 20245:36 pmRNSDirector/PDMR Shareholding
14th Feb 20249:00 amRNSDirector appointment
9th Feb 20244:26 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSCapital Markets Day
6th Feb 20244:58 pmRNSDirector/PDMR Shareholding
5th Feb 202411:29 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAmended Capital Markets Day start time
12th Jan 20247:00 amRNSNotice of Capital Markets Day
15th Dec 20234:51 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
10th Nov 202312:00 pmRNSBabcock signs £750 million infrastructure contract
7th Nov 20233:24 pmRNSHolding(s) in Company
30th Oct 20231:55 pmRNSHolding(s) in Company
28th Sep 20236:12 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM trading update
26th Sep 20235:57 pmRNSHolding(s) in Company
26th Sep 20235:56 pmRNSHolding(s) in Company
22nd Aug 20238:54 amRNSDirector/PDMR Shareholding
17th Aug 20232:52 pmRNSNotice of AGM
16th Aug 20235:16 pmRNSDirector/PDMR Shareholding
9th Aug 202310:00 amRNSDirector/PDMR Shareholding
4th Aug 20233:24 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:34 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:19 amRNSDirector/PDMR Shareholding
2nd Aug 20233:25 pmRNSDirector/PDMR Shareholding
2nd Aug 202310:22 amRNSDirector/PDMR Shareholding
31st Jul 20239:22 amRNSAnnual Financial Report
20th Jul 20237:16 amRNSFull year results for the year ended 31 March 2023
11th Jul 20237:00 amRNSDate of publication of FY23 preliminary statement
24th May 20238:54 amRNSDirectorate Change
20th Apr 20237:00 amRNSFY23 post close update and Type 31 contract update
1st Mar 20237:00 amRNSDisposal programme successfully concluded
15th Feb 20239:09 amRNSBabcock awarded contract to operate Skynet
2nd Feb 20238:13 amRNSDirectorate Change
20th Dec 202212:54 pmRNSStandard & Poor credit rating upgrade
9th Dec 20229:29 amRNSHolding(s) in Company
8th Dec 20229:06 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
9th Nov 20224:48 pmRNSHolding(s) in Company
3rd Nov 202212:13 pmRNSRestatement of pass-through revenue for HY22
3rd Nov 202211:08 amRNSRestatement of H1 2022 Results
21st Oct 20228:05 amRNSContract Win
18th Oct 20229:00 amRNSDirector appointment
13th Oct 202210:41 amRNSHolding(s) in Company
26th Sep 20224:00 pmRNSResult of AGM
26th Sep 20227:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.